Rozenblit, Mariya http://orcid.org/0000-0003-0244-429X
Blenman, Kim
Harigopal, Malini
Reisenbichler, Emily
Singh, Kamaljeet
Qing, Tao
Ibrahim, Eiman
Ramkissoon, Shakti
Asmelash, Sem
Lin, Hao-Kuen
Roberts, Mustimbo
Ross, Jeffrey
Huang, Richard S. P.
Pusztai, Lajos
Article History
Received: 22 March 2022
Accepted: 12 July 2022
First Online: 26 August 2022
Declarations
:
: S.R. J.R., and R. S.P.H are employees of Foundation Medicine, a wholly owned subsidiary of Roche and receive equity from Roche. M. Roberts is an employee and stockholder of BMS. L.P. has received consulting fees and honoraria from Seagen, Pfizer, Astra Zeneca, Merck, Novartis, Bristol Myers Squibb, Genentech, Eisai, Pieris, Immunomedics, Clovis, Syndax, H3Bio, Radius Health, Personalis, Natera, and Daiichi and institutional research funding from Seagen, AstraZeneca, Merck, Pfizer, and Bristol Myers Squibb.
: This study was approved by the Yale IRB.